Arbutus Reports First Quarter 2021 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Arbutus Biopharma (ABUS) Tops Q1 EPS by 2c
May 5, 2021 7:39 AM EDTArbutus Biopharma (NASDAQ: ABUS) reported Q1 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $2.11 million versus the consensus estimate of $3.31 million.
For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.
... More